Article Information
History
- March 25, 2019.
Article Versions
- You are currently viewing Version 1 of this article (March 25, 2019 - 13:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Clemens Messerschmidt1,2,
- Benedikt Obermayer1,2,
- Konrad Klinghammer3,
- Sebastian Ochsenreither3,4,5,
- Denise Treue6,
- Albrecht Stenzinger5,7,
- Hanno Glimm5,8,9,
- Stefan Fröhling5,10,11,
- Thomas Kindler5,12,13,
- Christian H. Brandts5,14,15,
- Klaus Schulze-Osthoff5,16,
- Wilko Weichert5,17,
- Ingeborg Tinhofer5,18,
- Frederick Klauschen5,6,
- Ulrich Keilholz4,5,
- Dieter Beule1,2,19 and
- Damian T. Rieke3,4,20
- 1Core Unit Bioinformatics, Berlin Institute of Health (BIH), 10178 Berlin, Germany
- 2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 3Department of Hematology and Oncology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 4Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
- 6Institute of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 7Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany
- 8Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Germany
- 9University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
- 10Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
- 11Department of Medical Oncology, NCT, Heidelberg, Germany
- 12Department of Hematology, Medical Oncology & Pneumology, University Medical Center, Mainz, Germany
- 13University Cancer Center Mainz (UCT), Johannes Gutenberg-University, Mainz, Germany
- 14University Cancer Center Frankfurt (UCT), Goethe University, Frankfurt, Germany
- 15Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany
- 16Interfaculty Institute of Biochemistry, Tübingen University, Germany
- 17Institute of Pathology, Technical University Munich, Munich, Germany
- 18Department of Radiooncology and Radiotherapy, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 19Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- 20Berlin Institute of Health (BIH), 10178 Berlin, Germany
- Corresponding Authors
: Dieter Beule, Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany And Damian T. Rieke, Charité Comprehensive Cancer Center, Charitéplatz 1, 10117 Berlin Damian.rieke{at}charite.de